UMB Bank’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
UMB Bank's CGEM Position: Q3 2026 in Review
UMB Bank held its Cullinan Therapeutics (CGEM) position steady in Q3 2026 at 685 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.
UMB Bank first reported a position in CGEM in Q4 2025 and has held it in 4 quarters since. The position peaked at $12.5K in Q2 2026. 182 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- UMB Bank held 685 shares of Cullinan Therapeutics worth $10.5K as of Q3 2026.
- UMB Bank left its Cullinan Therapeutics share count unchanged in Q3 2026.
- Cullinan Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q3 2026, its #1888 holding.
- UMB Bank first reported a position in Cullinan Therapeutics in Q4 2025 and has held it in 4 quarters since.
- UMB Bank's Cullinan Therapeutics position peaked at $12.5K in Q2 2026.
- 182 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.
Based on UMB Bank's 13F filing for Q3 2026, filed 6 Nov 2026.